UK markets closed

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.74+0.50 (+4.08%)
At close: 04:00PM EDT
12.68 -0.06 (-0.47%)
After hours: 06:18PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-207,043
-207,043
-92,534
-58,351
19,808
Depreciation & amortisation
10,969
10,969
10,624
10,251
9,150
Stock-based compensation
115,608
115,608
106,955
94,900
75,721
Change in working capital
29,655
29,655
11,796
29,069
-8,521
Accounts receivable
29,414
29,414
2,547
5,270
-30,354
Inventory
-8,919
-8,919
-4,342
2,483
-2,935
Other working capital
-100,429
-100,429
9,430
58,586
84,180
Other non-cash items
-23,179
-23,179
-3,752
3,007
3,260
Net cash provided by operating activities
-73,336
-73,336
30,788
82,756
99,148
Cash flows from investing activities
Investments in property, plant and equipment
-27,093
-27,093
-21,358
-24,170
-14,968
Purchases of investments
-1,003,741
-1,003,741
-1,297,888
-1,078,664
-607,879
Sales/maturities of investments
1,214,982
1,214,982
1,179,289
958,000
150,000
Net cash used for investing activities
184,148
184,148
-139,957
-144,834
-472,847
Cash flows from financing activities
Debt repayment
-10
-10
-28
-26
-150,028
Common stock issued
4,416
4,416
5,224
4,546
3,370
Net cash used provided by (used for) financing activities
15,787
15,787
15,491
25,702
440,209
Net change in cash
126,730
126,730
-93,775
-36,564
66,757
Cash at beginning of period
115,834
115,834
209,609
246,173
179,416
Cash at end of period
242,564
242,564
115,834
209,609
246,173
Free cash flow
Operating cash flow
-73,336
-73,336
30,788
82,756
99,148
Capital expenditure
-27,093
-27,093
-21,358
-24,170
-14,968
Free cash flow
-100,429
-100,429
9,430
58,586
84,180